MENU
+Compare
PRTA
Stock ticker: NASDAQ
AS OF
Jun 25 closing price
Price
$5.99
Change
-$0.08 (-1.32%)
Capitalization
322.42M

PRTA Prothena Corp Forecast, Technical & Fundamental Analysis

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases... Show more

Industry: #Biotechnology
PRTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PRTA with price predictions
Jun 25, 2025

PRTA's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for PRTA turned positive on June 05, 2025. Looking at past instances where PRTA's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where PRTA's RSI Indicator exited the oversold zone, of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on June 10, 2025. You may want to consider a long position or call options on PRTA as a result. In of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PRTA advanced for three days, in of 288 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRTA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PRTA broke above its upper Bollinger Band on June 16, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for PRTA entered a downward trend on June 10, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.737) is normal, around the industry mean (16.539). P/E Ratio (0.000) is within average values for comparable stocks, (59.016). PRTA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.300). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (2.336) is also within normal values, averaging (255.605).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. PRTA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRTA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
PRTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

PRTA is expected to report earnings to rise 5.36% to -117 cents per share on August 07

Prothena Corp PRTA Stock Earnings Reports
Q2'25
Est.
$-1.18
Q1'25
Beat
by $0.11
Q4'24
Missed
by $0.08
Q3'24
Beat
by $0.08
Q2'24
Beat
by $2.28
The last earnings report on May 08 showed earnings per share of -112 cents, beating the estimate of -123 cents. With 1.20M shares outstanding, the current market capitalization sits at 322.42M.
A.I. Advisor
published General Information

General Information

a developer of novel antibodies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
77 Sir John Rogerson’s Quay
Phone
+353 12362500
Employees
173
Web
https://www.prothena.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CLTAX15.75N/A
N/A
Catalyst/Lyons Tactical Allocation A
HCMNX18.81N/A
N/A
HCM Dividend Sector Plus A
JHURX33.77N/A
N/A
JPMorgan Emerging Markets Equity R3
ANPRX28.61N/A
N/A
Virtus NFJ Mid-Cap Value R6
RVPHX8.28-0.06
-0.72%
Royce Smaller-Companies Growth Invmt

PRTA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PRTA has been loosely correlated with RCKT. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if PRTA jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRTA
1D Price
Change %
PRTA100%
-1.32%
RCKT - PRTA
54%
Loosely correlated
-4.33%
SVRA - PRTA
46%
Loosely correlated
-3.95%
DNLI - PRTA
42%
Loosely correlated
+0.35%
KRYS - PRTA
39%
Loosely correlated
-0.81%
AXON - PRTA
38%
Loosely correlated
-1.16%
More